ÂÜÀòÂÒÂ×

Kelvin Muriuki is a highly experienced scientist with a focus on immunology and oncology, currently serving as Principal Associate Scientist at Strand Therapeutics since April 2022. Prior experience includes roles as Senior Research Associate and Research Associate II at Jnana Therapeutics from June 2020 to March 2022, as well as working as a Research Associate in the Oncology Program at Rubius Therapeutics between January 2019 and March 2020. Kelvin began a career in research at Brigham and Women's Hospital from February 2017 to January 2019 in the Wesemann's Lab, contributing significantly to the understanding of antibody repertoire diversification during B-Cell development. Earlier roles include technical and customer service positions, as well as leadership experience as President of the Equity Global Scholars Association. Kelvin earned a Bachelor of Arts in Integrated Biology from Harvard University in 2017, following education at Karima Boys' High School.